nandrolone has been researched along with levonorgestrel in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (27.78) | 18.7374 |
| 1990's | 2 (3.70) | 18.2507 |
| 2000's | 15 (27.78) | 29.6817 |
| 2010's | 16 (29.63) | 24.3611 |
| 2020's | 6 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Kollman, PA; Lee, DL; Marsh, FJ; Wolff, ME | 1 |
| Ban, F; Cherkasov, A; Fallahi, M; Hammond, GL; Santos-Filho, O; Thorsteinson, N | 1 |
| Jemilev, ZA; Komor, A; Schubert, K; Strecke, J | 1 |
| Koch, M; Peschke, T; Stracke, R | 1 |
| Freund, H; Freund, R; Kurischko, A; Meyer, M; Oettel, M; Stölzner, W | 1 |
| Chemnitius, KH; Dietz, K; Freund, H; Hesse, G; Oettel, M; Raj, MH; Stölzner, W | 1 |
| Härtl, A; Hillesheim, HG; Hoffmann, H; Kirchner, E; Knappe, H; Tkocz, R | 1 |
| Hillesheim, HG; Hoffmann, H | 1 |
| Anke, M; Chemnitius, KH; Dettmann, R; Deufrains, J; Furcht, R; Gaida, P; Güttner, J; Hesse, G; Hesse, V; Hillesheim, HG; Hoffmann, H; Holle, K; Horn, U; Keil, E; Klinger, G; Kramp, B; Lemke, H; Merbt, EM; Oettel, M; Robiller, F; Schimmel, I; Selzner, A; Stade, K; Strecke, J; Valentin, U | 1 |
| Goncharov, NP; Komor, A; Oettel, M; Schubert, K | 1 |
| Koch, M | 1 |
| Hesse, G; Kurischko, A; Löw, O; Oettel, M; Tkocz, H | 1 |
| Jemilev, ZA; Komor, A; Oettel, M; Schubert, K; Strecke, J | 1 |
| Güttner, J; Hillesheim, HG; Hoffmann, H; Oettel, M | 1 |
| Goncharov, NP; Komor, A; Oettel, M | 1 |
| Hillesheim, HG; Hoffmann, H; Oettel, M; Strecke, J | 1 |
| Joosten, JW; Kloosterboer, HJ; Schoonen, WG | 2 |
| Balogh, A; Gräser, G; Kauf, E; Klinger, G; Oettel, M; Vollanth, R | 1 |
| Hobe, G; Jäger, R; Klinger, G; Küntzel, B; Piater, T; Schön, R | 1 |
| Meczekalski, B; Słopień, R; Warenik-Szymankiewicz, A | 1 |
| Bauer, HH; Gross, W; Kuhl, H; Kutschera, E; Lee, JH; Mellinger, U; Moore, C; von Hayn, C; Wiegratz, I; Winkler, UH | 1 |
| Honjo, H; Hosoda, T; Kitawaki, J; Tanaka, K; Tatsumi, H | 1 |
| Kuhl, H; Kutschera, E; Lee, JH; Mellinger, U; Moore, C; Wiegratz, I; Winkler, UH | 2 |
| Kamischke, A; Nieschlag, E; Zitzmann, M | 1 |
| Mueck, AO; Seeger, H; Wallwiener, D | 1 |
| Borja-Cacho, E; Cooney, AJ; García-Becerra, R; Larrea, F; Lemus, AE; Pérez-Palacios, G | 1 |
| Kuhl, H; Kutschera, E; Lee, JH; Wiegratz, I; Winkler, UH | 1 |
| Fushiki, S; Hirasugi, Y; Honjo, H; Hosoda, T; Iwasa, K; Kawata, M; Kikuchi, N; Kitawaki, J; Mihara, M; Oida, N; Tatsumi, H; Yamamoto, H | 1 |
| Rajalakshmi, M | 1 |
| Ahrendt, HJ; Makalová, D; Mansour, D; Mellinger, U; Parke, S | 1 |
| Kitawaki, J | 1 |
| Assmann, A; Dinger, J; Minh, TD; Möhner, S | 1 |
| Duijkers, I; Junge, W; Klipping, C; Mellinger, U; Parke, S; Serrani, M | 1 |
| Junge, W; Mellinger, U; Parke, S; Serrani, M | 1 |
| Helmerhorst, FM; Lopez, LM; Raps, M; Van Vliet, HA | 1 |
| Mocciaro, R; Morelli, M; Sacchinelli, A; Venturella, R; Zullo, F | 1 |
| Macìas, G; Mellinger, U; Merki-Feld, GS; Parke, S; Serrani, M | 1 |
| Bitzer, J; Davis, SR; Giraldi, A; Mellinger, U; Nappi, RE; Palacios, S; Parke, S; Serrani, M | 1 |
| Avraham, S; Seidman, DS | 1 |
| Mellinger, U; Parke, S; Petraglia, F; Römer, T; Serrani, M | 1 |
| Calaf, J; Canals, I; Crespo, C; Cristóbal, I; Espinós, B; Lete, I | 1 |
| Chabbert-Buffet, N; Jamin, C; Lello, S; Lete, I; Lobo, P; Nappi, RE; Pintiaux, A | 1 |
| Apter, D; Beekman, L; Coelingh Bennink, HJ; Foidart, JM; Maillard, C; Mawet, M; Zimmerman, Y | 1 |
| Dinger, J; Do Minh, T; Heinemann, K | 1 |
| Barnett, C; Dinger, J; Do Minh, T; Hagemann, C; Heinemann, K | 1 |
| Han, HY; Jung, YW; Kang, BH; Ko, YB; Lee, KH; Lee, M; Song, SY; Yang, JB; Yoo, HJ | 1 |
| Abdelhakim, AM; Ahmed, SA; AlAmodi, AA; Ali, AS; Ashour, K; El Kattan, EAM; Elsherbini, M; Fathi, M; Haggag, H; Keshta, NHA; Salah, DM; Samy, A; Shareef, MA; Shatat, HBAE; Sileem, SA; Taher, A | 1 |
| Ainsworth, AJ; Cope, AG; Stewart, EA | 1 |
| Lumbiganon, P; Pattanittum, P; Sangkomkamhang, US | 1 |
| Haverinen, AH; Heikinheimo, O; Hiltunen, L; Kangasniemi, MH; Lassila, R; Luiro, KM; Piltonen, TT; Sainio, S; Szanto, T; Tapanainen, JS | 1 |
| Arffman, RK; Haverinen, A; Heikinheimo, O; Hustad, S; Kangasniemi, MH; Luiro, K; Piltonen, TT; Tapanainen, JS | 1 |
| Guo, W; Hu, S; Lin, Y; Shen, Y | 1 |
8 review(s) available for nandrolone and levonorgestrel
| Article | Year |
|---|---|
Use of progestins in male contraception.
Topics: Asian People; Contraception; Cyproterone Acetate; Desogestrel; Humans; Levonorgestrel; Male; Medroxyprogesterone; Nandrolone; Progestins; Steroids; Testosterone; Time Factors; White People | 2003 |
Male contraception: expanding reproductive choice.
Topics: Androgens; Condoms; Contraception; Contraceptive Agents; Contraceptive Agents, Male; Contraceptives, Oral; Contraceptives, Postcoital, Hormonal; Cyproterone; Desogestrel; Dihydrotestosterone; Epitopes; Estrogens; Hormones; Humans; Levonorgestrel; Male; Nandrolone; Spermatogenesis; Spermatozoa; Testosterone; Time Factors | 2005 |
[Maintenance therapy for endometriosis].
Topics: Clinical Trials as Topic; Contraceptives, Oral; Danazol; Drug Therapy, Combination; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Levonorgestrel; Nandrolone; Pelvic Pain; Progesterone Congeners | 2010 |
Quadriphasic versus monophasic oral contraceptives for contraception.
Topics: Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medication Adherence; Menstruation; Nandrolone; Randomized Controlled Trials as Topic; Uterine Hemorrhage | 2011 |
Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
Topics: Androstenes; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Drug Combinations; Drug Therapy, Combination; Estradiol; Estrogens; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Lipid Metabolism; Megestrol; Nandrolone; Venous Thromboembolism | 2015 |
Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials.
Topics: Contraceptive Agents, Hormonal; Contraceptives, Oral, Hormonal; Dysmenorrhea; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Hydrocarbons, Fluorinated; Levonorgestrel; Nandrolone; Network Meta-Analysis; Pelvic Pain; Pyrimidines; Randomized Controlled Trials as Topic; Visual Analog Scale | 2021 |
Current and Future Medical Therapies for Adenomyosis.
Topics: Adenomyosis; Dysmenorrhea; Female; Hormone Antagonists; Humans; Levonorgestrel; Menorrhagia; Nandrolone; Pain Measurement; Quality of Life | 2020 |
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
Topics: Adult; Antineoplastic Agents, Hormonal; Bias; Contraceptives, Oral; Desogestrel; Female; Goserelin; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Nandrolone; Norethindrone Acetate; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2020 |
15 trial(s) available for nandrolone and levonorgestrel
| Article | Year |
|---|---|
Effects of two oral contraceptives on plasma levels of insulin-like growth factor I (IGF-I) and growth hormone (hGH).
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Levonorgestrel; Linear Models; Nandrolone; Time Factors | 2000 |
Effect of dienogest-containing oral contraceptives on lipid metabolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Estradiol; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Nandrolone; Statistics, Nonparametric | 2002 |
Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.
Topics: Adolescent; Adult; Contraceptives, Oral; Dehydroepiandrosterone Sulfate; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Levonorgestrel; Nandrolone; Reference Values; Sex Hormone-Binding Globulin; Testosterone; Thyroxine-Binding Proteins; Treatment Outcome | 2003 |
Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Contraceptives, Oral, Combined; Double-Blind Method; Drug Administration Schedule; Endothelin-1; Estradiol; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Nandrolone; Thyroid Hormones; Treatment Outcome | 2003 |
Effect of four oral contraceptives on hemostatic parameters.
Topics: alpha-2-Antiplasmin; Antithrombins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Estradiol; Ethinyl Estradiol; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Homeostasis; Humans; Levonorgestrel; Nandrolone; Peptide Fragments; Plasminogen; Plasminogen Inactivators; Protein C; Prothrombin; Tissue Plasminogen Activator | 2004 |
Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Metrorrhagia; Middle Aged; Nandrolone; Patient Satisfaction; Treatment Outcome; Young Adult | 2009 |
Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
Topics: Activated Protein C Resistance; Adolescent; Adult; Antigens; Antithrombin III; Blood Pressure; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Combinations; Estradiol; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Levonorgestrel; Middle Aged; Nandrolone; Patient Compliance; Peptide Fragments; Protein C; Protein Precursors; Protein S; Prothrombin; Sex Hormone-Binding Globulin; Young Adult | 2011 |
Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.
Topics: Adult; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Glucose Tolerance Test; Hematologic Tests; Hemostasis; Humans; Levonorgestrel; Lipids; Middle Aged; Nandrolone; Thyroid Function Tests; Treatment Outcome; Young Adult | 2011 |
Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
Topics: Adult; Contraceptives, Oral, Combined; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Nandrolone; Pelvic Pain; Substance Withdrawal Syndrome; Young Adult | 2013 |
Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Drug Substitution; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Nandrolone; Sexual Dysfunction, Physiological; Young Adult | 2013 |
Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea.
Topics: Adolescent; Adult; Double-Blind Method; Drug Combinations; Dysmenorrhea; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Nandrolone; Time Factors; Treatment Outcome; Young Adult | 2014 |
Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA).
Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Estetrol; Estradiol; Female; Humans; Levonorgestrel; Metrorrhagia; Nandrolone | 2016 |
Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Estradiol; Estrogens; Ethinyl Estradiol; Female; Fibrin; Humans; Levonorgestrel; Nandrolone; Progestins; Thrombin; Thromboplastin; Young Adult | 2022 |
Effects of estradiol- and ethinylestradiol-based contraceptives on adrenal steroids: A randomized trial.
Topics: Contraceptives, Oral, Combined; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Nandrolone | 2022 |
Compare the Efficacy of Dienogest and the Levonorgestrel Intrauterine System in Women with Adenomyosis.
Topics: Adenomyosis; Female; Humans; Levonorgestrel; Nandrolone; Pain | 2023 |
31 other study(ies) available for nandrolone and levonorgestrel
| Article | Year |
|---|---|
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
Topics: Androstenes; Animals; Guinea Pigs; Humans; Hydroxyprogesterones; Protein Binding; Rabbits; Receptors, Progesterone; Sheep; Steroids; Structure-Activity Relationship | 1977 |
An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
Topics: Binding Sites; Binding, Competitive; Computer Simulation; Databases as Topic; Humans; Ligands; Linear Models; Models, Molecular; Predictive Value of Tests; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Sex Hormone-Binding Globulin; Steroids | 2008 |
[Chromosome analysis of female baboons following treatment with STS 557 and levonorgestrel].
Topics: Animals; Bone Marrow Cells; Chromosome Aberrations; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Nandrolone; Norgestrel; Papio; Progesterone Congeners; Stereoisomerism | 1985 |
Effects of antifertility estrogens and progestins on the endometrial surface of early pregnant rats. A scanning electron microscopic study.
Topics: Animals; Contraceptives, Oral, Combined; Endometrium; Estriol; Estrogens; Female; Levonorgestrel; Mestranol; Microscopy, Electron, Scanning; Microvilli; Nandrolone; Norgestrel; Pregnancy; Pregnancy, Animal; Progestins; Rats; Rats, Inbred Strains | 1985 |
Progestagenic and antigonadotrophic activities of STS 557.
Topics: Administration, Oral; Animals; Chlormadinone Acetate; Contraceptives, Oral, Combined; Female; Gonadotropins; Injections, Subcutaneous; Levonorgestrel; Nandrolone; Norethindrone; Norgestrel; Ovulation; Progesterone Congeners; Rabbits; Rats; Rats, Inbred Strains; Species Specificity | 1983 |
Inhibition of male fertility by STS 557.
Topics: Animals; Contraceptives, Oral, Combined; Fertility; Fructose; Gonadotropins; Levonorgestrel; Male; Nandrolone; Norgestrel; Rabbits; Reproduction; Semen; Sialic Acids; Sperm Motility; Testosterone | 1983 |
Pharmacological activities of the progestin STS 557.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Anticonvulsants; Body Temperature; Contraceptives, Oral, Combined; Dogs; Drinking; Eating; Guinea Pigs; Hemodynamics; Lethal Dose 50; Levonorgestrel; Male; Mice; Motor Activity; Muscle, Smooth; Nandrolone; Norgestrel; Progesterone Congeners; Rats | 1983 |
Data on acute toxicity of the progestin STS 557.
Topics: Animals; Body Temperature; Body Weight; Contraceptives, Oral, Combined; Drinking; Eating; Female; Lethal Dose 50; Levonorgestrel; Male; Mice; Motor Activity; Nandrolone; Norgestrel; Progesterone Congeners; Rabbits; Species Specificity | 1983 |
Long term toxicological studies on the progestin STS 557.
Topics: Animals; Body Weight; Contraceptives, Oral, Combined; Dogs; Eating; Female; Glucose Tolerance Test; Hormones; Levonorgestrel; Male; Nandrolone; Norgestrel; Organ Size; Progesterone Congeners; Rats; Time Factors | 1983 |
STS 557 as an interceptive in baboons.
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Female; Levonorgestrel; Menstruation; Nandrolone; Norgestrel; Papio; Progesterone; Progesterone Congeners | 1983 |
Influence of STS 557 on the mitotic activity in the endometrium of ovariectomized mice and comparison with the effects of progesterone and levonorgestrel.
Topics: Animals; Castration; Contraceptives, Oral; Contraceptives, Oral, Combined; Endometrium; Female; Levonorgestrel; Mice; Mitosis; Nandrolone; Norgestrel; Progesterone | 1984 |
Effects of levonorgestrel and STS 557 on testis in rodents.
Topics: Animals; Castration; DNA; Female; Fertility; Levonorgestrel; Libido; Luteinizing Hormone; Male; Nandrolone; Norgestrel; Organ Size; Pregnancy; Rats; Sexual Maturation; Testis | 1980 |
[Chromosomal analysis of baboons and their mothers, following application to mothers of potentially post-ovulation fertility-inhibiting steroids (author's transl)].
Topics: Animals; Bone Marrow Cells; Chromosome Aberrations; Chromosome Mapping; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Female; Levonorgestrel; Lymphocytes; Nandrolone; Norgestrel; Papio; Pregnancy | 1981 |
Toxicity of the progestagen STS 557 compared to levonorgestrel in beagles after oral administration for 6 months.
Topics: 11-Hydroxycorticosteroids; Administration, Oral; Animals; Dogs; Female; Levonorgestrel; Male; Nandrolone; Norgestrel; Progesterone Congeners; Time Factors | 1982 |
Further report on the interceptive STS 557 in baboons.
Topics: Administration, Oral; Animals; Contraceptives, Oral, Combined; Female; Levonorgestrel; Nandrolone; Norgestrel; Papio; Pregnancy; Progesterone | 1982 |
[Changes in vaginal cytograms of female beagle dogs during toxicologic long-term examinations of gestagens].
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dogs; Estrus; Female; Levonorgestrel; Long-Term Care; Menstruation; Nandrolone; Norgestrel; Pregnancy; Vaginal Smears | 1982 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Desogestrel; Estradiol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Statistical; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 1995 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured | 1995 |
Non-protein bound dienogest in serum and salivary dienogest in women taking the oral contraceptives Certostat and Valette.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral; Female; Humans; Levonorgestrel; Nandrolone; Protein Binding; Radioimmunoassay; Saliva; Ultrafiltration | 2001 |
Estimation of hormone replacement therapy influence on serum galanin level in postmenopausal women.
Topics: Adult; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Galanin; Humans; Levonorgestrel; Middle Aged; Nandrolone; Norethindrone; Norethindrone Acetate; Postmenopause | 2001 |
Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins.
Topics: Arteriosclerosis; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Humans; Intercellular Adhesion Molecule-1; Interleukin-1; Levonorgestrel; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Receptors, Androgen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Umbilical Veins; Vascular Cell Adhesion Molecule-1 | 2002 |
Endogenous estradiol metabolism during treatment with oral contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Hydroxyestrones; Levonorgestrel; Nandrolone; Norethindrone; Premenopause; Randomized Controlled Trials as Topic | 2004 |
Comparative evaluation of androgen and progesterone receptor transcription selectivity indices of 19-nortestosterone-derived progestins.
Topics: Androgens; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Genes, Reporter; Genetic Vectors; HeLa Cells; Humans; Levonorgestrel; Ligands; Nandrolone; Norethindrone; Norpregnenes; Plasmids; Progestins; Protein Biosynthesis; Receptors, Androgen; Receptors, Progesterone; Transcription, Genetic; Transcriptional Activation; Transfection; Trypsin | 2004 |
Progestins and estrogens and Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cell Adhesion; Cells, Cultured; Cognition; Estradiol; Estradiol Congeners; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Progesterone Congeners; Rats | 2005 |
Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Germany; Humans; Levonorgestrel; Logistic Models; Middle Aged; Mineralocorticoid Receptor Antagonists; Nandrolone; Risk Factors; Venous Thromboembolism; Young Adult | 2010 |
Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients.
Topics: Adult; Combined Modality Therapy; Contraceptive Agents, Female; Drug Combinations; Endometriosis; Estradiol; Estrogens; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Nandrolone; Patient Satisfaction; Pelvic Pain; Postoperative Care; Receptors, Progesterone; Retrospective Studies; Secondary Prevention | 2013 |
Surgery versus pharmacological treatment for endometriosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Contraceptives, Oral, Combined; Endometriosis; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Infertility, Female; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Nandrolone; Pelvic Pain; Progestins | 2014 |
Cost-effectiveness analysis in the treatment of heavy menstrual bleeding in Spain.
Topics: Contraceptives, Oral, Combined; Cost-Benefit Analysis; Drug Combinations; Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Models, Theoretical; Nandrolone; Spain | 2015 |
Impact of estrogen type on cardiovascular safety of combined oral contraceptives.
Topics: Adult; Cardiovascular Diseases; Contraceptives, Oral, Combined; Estradiol; Europe; Female; Follow-Up Studies; Humans; Incidence; Levonorgestrel; Longitudinal Studies; Nandrolone; Patient Reported Outcome Measures; Proportional Hazards Models; Prospective Studies; Surveys and Questionnaires; United States; Venous Thromboembolism; Young Adult | 2016 |
Fertility and combined oral contraceptives - unintended pregnancies and planned pregnancies following oral contraceptive use - results from the INAS-SCORE study.
Topics: Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Europe; Female; Fertility; Follow-Up Studies; Humans; Levonorgestrel; Medication Adherence; Nandrolone; Pregnancy; Pregnancy Rate; Pregnancy, Unplanned; Prospective Studies; United States; Withholding Treatment; Young Adult | 2017 |
Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis.
Topics: Adult; Contraceptive Agents, Female; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Middle Aged; Nandrolone; Outcome Assessment, Health Care; Pain, Postoperative; Pelvic Pain; Young Adult | 2018 |